Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2017

Sep 7, 2017

30786_dirs_2017-09-06_a4775664-414c-4ebb-a033-7ab397a5cd53.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-09-05

Reporting Person: HUTTON RONALD W (Vice President and Treasurer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-09-05 Restricted Stock Units $0 A 900 Acquired Bio-Rad A Common Stock (900) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 2977.191 Direct

Footnotes

F1: Includes 9.8583, 9.6805 and 7.5328 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/16, 3/31/17 and 6/30/17, respectively.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.